Abstract
There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the repair of double-strand breaks by homology-independent or -dependent mechanisms is distinguished by the accumulation of green or red fluorescence, respectively. Using a genome-wide human esiRNA (endoribonuclease-prepared siRNA) library, we isolate genes that control the recombination/end-joining ratio. Here we report that two distinct sets of genes are involved in the control of the balance between NHEJ and HR: those that are required to facilitate recombination and those that favour NHEJ. This last category includes CCAR2/DBC1, which we show inhibits recombination by limiting the initiation and the extent of DNA end resection, thereby acting as an antagonist of CtIP.
Cite
CITATION STYLE
López-Saavedra, A., Gómez-Cabello, D., Domínguez-Sánchez, M. S., Mejías-Navarro, F., Fernández-Ávila, M. J., Dinant, C., … Huertas, P. (2016). A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection. Nature Communications, 7. https://doi.org/10.1038/ncomms12364
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.